metformin and tirzepatide SURPASS‑EARLY evaluated starting early in type 2 diabetes vs. conventional step-therapy. In adults with early T2D on metformin, tirzepatide produced larger 2‑year reductions in HbA1c… How does metformin compare to

Wegovy, conversely, is administered as a once-weekly subcutaneous injection and can be given at any time of day, with or without food

Understanding when injections are clinically appropriate helps patients make informed decisions about their care

Systemic benefits beyond skin appearance Important Note: Individual outcomes vary

You can view the published Institute BCN Advanced Protocols by clicking the link

The authors thank the following persons for their contributions to this work: Dolores Otero-Criado, Carlos Carvajales Fernndez, Rosa Zurdo-Baz and Raisa Gonzlez-Prez

The Wegovy pill, which is a new GLP-1 tablet containing the same active ingredient as Wegovy (semaglutide), may become available in the UK in summer 2026